Related Experiment Video
Updated: Jul 28, 2026
23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Problems and solutions for the Stop TB partnership
1Department of Biomathematics, University of California Los Angeles School of Medicine, Los Angeles 90095, USA. sblower@biomath.medsch.ucla.edu
The Lancet. Infectious Diseases
|July 30, 2002
Summary
Global tuberculosis control faces challenges. Current detection and treatment rates are low, making World Health Organization (WHO) targets unlikely to be met by 2013 without intervention.
Area of Science:
- Public Health
- Epidemiology
- Infectious Disease Control
Background:
- The Stop TB partnership aims to achieve global tuberculosis control through specific targets.
- Key targets include detecting 70% of new smear-positive cases and successfully treating 85% under Directly Observed Treatment, Short-course (DOTS) by 2005.
Purpose of the Study:
- To evaluate the feasibility of achieving the World Health Organization's (WHO) global tuberculosis control targets.
- To analyze current case detection and treatment success rates and project future trends.
Main Methods:
- Analysis of existing tuberculosis case detection and treatment success data.
- Linear extrapolation of current trends to predict future achievement of WHO targets.
Main Results:
- Current case detection rates are significantly below the WHO target (27% vs. 70%).
- Treatment success rates in many regions also fall short of the 85% WHO target.
- Linear extrapolation suggests WHO case detection targets may not be met until 2013.
Conclusions:
- The projected timeline for achieving WHO global tuberculosis targets is likely unrealistic based on current trends.
- Urgent interventions and revised strategies are necessary to improve tuberculosis case detection and treatment success rates.
- Potential solutions are discussed to address the shortfall in meeting global tuberculosis control goals.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...